Secondary Logo

Institutional members access full text with Ovid®

Adverse drug interactions

Baxter, Karen; Sharp, Jennifer M

Adverse Drug Reaction Bulletin: February 2008 - Volume - Issue 248 - p 951–954
doi: 10.1097/FAD.0b013e328302c585
Original Article
Buy

Drug interactions are numerous and varied, but not always clinically significant. Here we consider those factors that determine whether or not a drug interaction becomes clinically important, and the drugs commonly implicated in interactions.

Stockley's Drug Interactions, Royal Pharmaceutical Society, London, UK

Correspondence to Karen Baxter, Stockley's Drug Interactions, Royal Pharmaceutical Society, 1 Lambeth High Street, London, SE1 7JN, UK

Editor: R E Ferner, MSc, MD, FRCP, Director of the West Midlands Centre for Adverse Drug Reaction Reporting and Consultant Physician at City Hospital, Birmingham, UK. Assistant Editor: Mr C Anton, MA, MEng. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield, Denmark: Professor J S Schou; England: Dr J K Aronson; Ireland: Professor J Feely; Netherlands: Professor C J van Boxtel, Dr B H Ch Stricker; New Zealand: Dr T Maling; Scotland: Dr D N Bateman; Wales: Professor P A Routledge.

© 2008 Lippincott Williams & Wilkins, Inc.